Saudi Chemical Co.

What Saudi Chemical Co. does

Saudi Chemical Company Holding is a publicly listed Saudi Arabian industrial investment holding company (Tadawul: 2230), founded in 1970, with a stated capital of SAR 843.2 million and operations across chemical manufacturing and pharmaceutical distribution. The group comprises five wholly-owned subsidiaries organized into two core verticals: (1) explosives — Saudi Chemical Company Limited operates as the leading domestic manufacturer of civil and military explosives, running three strategically located factories in Riyadh, Jeddah, and the Northern Borders Area, supported by multiple distribution sites across the Kingdom; and (2) pharmaceuticals — Sitco Pharma operates one of the largest pharmaceutical distribution networks in Saudi Arabia (including cold-chain distribution of vaccines, insulin, and hormones), AJA Pharma manufactures and markets pharmaceutical products in partnership with global pharma leaders for the Saudi and GCC markets, and CCCI handles wholesale and retail trade of medicines and medical equipment.

The group is vertically integrated upstream through Suez International Nitrate Company (SINCO), an Egypt-based wholly-owned subsidiary producing Ammonium Nitrates at a capacity of 85,000 metric tons per year to secure raw material supply for the explosives business. Revenue streams span explosives supply (government defense, mining, and infrastructure buyers), pharmaceutical distribution (hospitals, pharmacies, and health institutions), pharmaceutical manufacturing (GCC market), ammonium nitrate production (export-eligible), and medical equipment wholesale. No customer logos or pricing models are publicly disclosed. The company is actively executing growth initiatives aligned with Saudi Arabia's Vision 2030, including a SAR 56.5 million Jeddah warehouse project (contracted July 2026) and a EUR 4 million localization partnership with Bosnia's TRB. The workforce is reported at 501-1,000 employees.

Financially, the group has expanded revenue from approximately $3.70B in 2022 to $6.88B in 2025 (cumulative growth of ~86%, ~23% CAGR), with net income rising from ~$80M to ~$335M (SAR-denominated per source) and EBITDA from ~$217M to ~$552M over the same period. Gross margin has remained in the 12-14% band, with margin expansion driven by operating leverage as scale grew. No AI/ML capabilities, patents, awards, or named leadership bios are disclosed in the source material.

Name

Saudi Chemical Co.

Legal name

Saudi Chemical Company Holding

Website

https://saudichemical.com

Company type

Public

Founded year

1970

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Saudi Chemical Company Holding is a publicly listed Saudi industrial investment company operating five subsidiaries in civil/military explosives manufacturing, pharmaceutical distribution and manufacturing, ammonium nitrate production, and medical equipment trading, primarily serving Saudi government, healthcare, and GCC markets.

Ownership category

akta.pro rank

Product category

Industrial Chemicals and Explosives Manufacturing

NAICS

Explosives Manufacturing (32592), Explosives Manufacturing (325920), Basic Chemical Manufacturing (3251), Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Chemicals & Allied Products (2800), Industrial Inorganic Chemicals (2810), Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Military-Grade Explosives & Energetic Materials (IMAEALAE)

akta.pro secondary industries

Oxidizers & Organic Peroxides Storage (Class 5) (TLALAHAC), Specialty Pharmaceutical Distributors (HLAIAJAB), Controlled Substances & Compliance-Focused Pharmaceutical Distributors (HLAIAJAN)

Keywords

• Civil explosives manufacturing
• Military explosives production
• Pharmaceutical distribution
• Ammonium nitrate production
• Pharmaceutical manufacturing

Headquarters

HQ city

Al Malaz

HQ country

Saudi Arabia

HQ region

Middle East

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Infrastructure, Marketing or Sales

Revenue model

1. Chemical Manufacturing (Civil and Military Explosives): Manufacturing and distribution of civil and military explosives through three factories and multiple distribution sites across the Kingdom, supplying both local and international markets.
2. Pharmaceutical Distribution (Sitco Pharma): Distribution of pharmaceutical products across Saudi Arabia, including cold-chain distribution of vaccines and temperature-sensitive medicines (insulin, hormones) through a nationwide distribution network.
3. Pharmaceutical Manufacturing (AJA Pharma): Manufacturing and marketing of pharmaceutical products in Saudi Arabia and the GCC in partnership with global pharmaceutical partners.
4. Ammonium Nitrate Production (SINCO, Egypt): Production of Ammonium Nitrates at Suez International Nitrate Company in Egypt with 85,000 metric tons per year capacity, supporting vertical supply chain integration.
5. Medical Equipment Wholesale/Retail (CCCI): Wholesale and retail trade of medicines, medical materials, and medical equipment.

Distribution channels3 records

Marketing channels1 record

Core offering

Saudi Chemical Company Holding is a Saudi-based investment holding company operating five subsidiaries: it manufactures civil and military explosives through three factories in Riyadh, Jeddah, and the Northern Borders Area; distributes pharmaceutical products (including cold-chain vaccines and temperature-sensitive medicines) across Saudi Arabia via Sitco Pharma; manufactures pharmaceutical products in the GCC through AJA Pharma; produces Ammonium Nitrate (85,000 metric tons per year capacity) at SINCO in Egypt; and trades medicines, medical materials, and equipment through CCCI.

Product overview

Saudi Chemical Company Holding operates as a diversified industrial investment company with a capital of SAR 843.2 million, managing five subsidiary companies across chemical and pharmaceutical sectors. The portfolio includes: Saudi Chemical Company Limited (core explosives manufacturing with three factories), Sitco Pharma (pharmaceutical distribution across Saudi Arabia), AJA Pharma (pharmaceutical manufacturing in Saudi Arabia and GCC), SINCO (Ammonium Nitrate production in Egypt with 85,000 metric tons/year capacity), and CCCI (wholesale/retail of medical supplies). The company follows vertical growth strategies to secure raw materials and diversify investments across trading, manufacturing, and distribution.

Differentiator

Problem solved

Functional benefit

Brands

• Sitco Pharma: Saudi International Trading Company focused on pharmaceutical product distribution in Saudi Arabia, one of the largest pharmaceutical distributors and national distributors of chilled vaccines and medicines.
• AJA Pharma
• SINCO
• CCCI

Products and services

• Saudi Chemical Company Limited (Civil and Military Explosives) Leading Saudi manufacturer of civil and military explosives supplying construction, mining, infrastructure, and defense customers in Saudi Arabia and international markets through three factories and a nationwide distribution network.
• Sitco Pharma (Saudi International Trading Company) Pharmaceutical distribution services across all regions of Saudi Arabia, including specialized cold-chain distribution of vaccines, insulin, and hormone products requiring special storage and transportation conditions for healthcare institutions, pharmacies, and health authorities.
• AJA Pharma Manufacturing and marketing of a wide range of pharmaceutical products in Saudi Arabia and the GCC in accordance with the latest manufacturing practices, in cooperation with leading global pharmaceutical partners.
• SINCO (Suez International Nitrate Company) Ammonium Nitrate Production of Ammonium Nitrate at 85,000 metric tons per year capacity in Suez, Egypt, supplying raw material for explosives manufacturing within the group and serving international export markets.
• CCCI (Chemical Commercial Investment Company Ltd.) Wholesale and retail trade of medicines, medical materials, and medical equipment in Saudi Arabia.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered minor and core.

• Rafic A. Kreidie ContractingminorImplementation/ SI/ Consulting Partner · 28 July 2026Saudi Chemical awarded the construction and civil works contract for a new warehouse project in Jeddah to Rafic A. Kreidie Contracting. The project is part of Saudi Arabia's Vision 2030 goals to diversify its economy and strengthen its industrial base.
• Dr. Mohamed Al-Amri & Co.minorOthers · 15 June 2026Dr. Mohamed Al-Amri & Co. was appointed as auditor for the company through 2028, with ratified ongoing transactions valued at approximately SAR 7 million annually through February 2028.
• TRB (Bosnia)coreStrategic or Co-development PartnerSaudi Chemical Co. reported an ongoing EUR 4 million localization deal with Bosnia's TRB. This international partnership supports technology transfer and local manufacturing capabilities.

Scale indicators7 records

Recent moves7 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/saudi_chemical
• LinkedInlinkedin.com/company/saudi-chemical-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Saudi Chemical Co.